Crocs: Rees foundation proposes $1.53M share sale

The proposed sale is listed at an aggregate market value of $1,528,066, alongside two earlier trust sales in August 2026.

Available on EDGAR 11/03/2026 - 04:39 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:39 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Crocs, Inc. (CROX) reports a proposed sale by The Rees Family Foundation, Inc. of 10,000 common shares through Morgan Stanley Smith Barney LLC, with an approximate sale date of November 3, 2026. The proposed shares are listed as having been received as a gift from affiliate V. Andrew Rees on November 20, 2025, and have an aggregate market value of $1,528,066. Separately, The Rees Family Living Trust reported sales of 19,072 shares for $2,649,320.13 on August 10, 2026, and 10,928 shares for $1,508,248.20 on August 7, 2026.

Key Figures

Proposed shares for sale: 10,000 common shares Aggregate market value: $1,528,066 Trust shares sold: 19,072 shares +3 more

6 metrics

Proposed shares for sale 10,000 common shares The Rees Family Foundation, Inc.; approximate sale date November 3, 2026

Aggregate market value $1,528,066 Proposed sale by The Rees Family Foundation, Inc.

Trust shares sold 19,072 shares The Rees Family Living Trust, August 10, 2026

Reported amount $2,649,320.13 The Rees Family Living Trust sale on August 10, 2026

Trust shares sold 10,928 shares The Rees Family Living Trust, August 7, 2026

Reported amount $1,508,248.20 The Rees Family Living Trust sale on August 7, 2026

Key Terms

Rule 144, Affiliate

2 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Affiliate regulatory

"Gift from Affiliate"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CROX shares does The Rees Family Foundation plan to sell?

The Rees Family Foundation, Inc. lists a proposed sale of 10,000 common shares, with an approximate sale date of November 3, 2026, through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of $1,528,066.

How did The Rees Family Foundation acquire the CROX shares?

The 10,000 common shares are listed as received as a gift from affiliate V. Andrew Rees on November 20, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001609901
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CROCS, INC.
SEC File Number	000-51754
Address of Issuer	500 ELDORADO BOULEVARD BUILDING 5 BROOMFIELD COLORADO 80021
Phone	3038487000
Name of Person for Whose Account the Securities are To Be Sold	THE REES FAMILY FOUNDATION, INC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	1528066.00	45725000	11/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Gift from Affiliate	V. Andrew Rees		03/17/2020	10000		NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
THE REES FAMILY LIVING TRUST 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	08/10/2026	19072	2649320.13
THE REES FAMILY LIVING TRUST 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	08/07/2026	10928	1508248.20

144: Remarks and Signature

Remarks
Date of Notice	11/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Rees
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)